Clinicopathologic Characteristics Associated with Prognosis in Ocular Extranodal Marginal Zone B Cell Lymphoma
- PMID: 35744081
- PMCID: PMC9229471
- DOI: 10.3390/medicina58060818
Clinicopathologic Characteristics Associated with Prognosis in Ocular Extranodal Marginal Zone B Cell Lymphoma
Abstract
Background and Objectives: Extranodal marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) type is the most common subtype of the ocular adnexal lymphoma. Despite its excellent prognosis, some patients experience partial remission or progressive disease. We aimed to evaluate clinicopathologic differences in the treatment responder group by comparing complete remission (CR) and non-complete remission (non-CR). Materials and Methods: This study retrospectively reviewed 48 patients who were diagnosed with ocular adnexal MALT lymphoma at Ulsan University Hospital between March 2002 and August 2018. Patients who were followed up for less than 6 months were excluded. Histologic and clinical features were analyzed. The patients were divided into two groups: CR and non-CR. Results: Among the 48 patients, 33 achieved CR and 15 achieved non-CR during the median follow-up period of 40.00 months (range, 7-109 months). In univariable analysis, more patients tend to undergo treatment in the CR group, and post-radiotherapy (post-RT) SUVmax, PET and serum lactate dehydrogenase (LDH) levels were higher in the non-CR group (p = 0.043, p = 0.016, and p = 0.042, respectively). In a multivariable analysis, only application of treatment, including radiotherapy or chemotherapy with immunotherapy, was related to CR (odd ratio 7.301, 95% confidence interval 1.273-41.862, p = 0.026). In subgroup analysis according to the site of involvement, none of the variables were significant except for the post-RT SUVmax of PET and level of serum LDH in the non-conjunctiva group (p = 0.026, and p = 0.037, respectively). Seven (14.6%) patients had a recurrence, and those with a recurring site other than the primary site had a higher Ki-67 labeling index, although it was not statistically significant (9.56% vs. 18.00%, p = 0.095). Conclusions: Although belonging to the early stages, the non-CR rate was high in patients with high serum LDH levels, and recurred patients had higher Ki-67. Thus, considering active treatment is recommended in this group of patients.
Keywords: MALT lymphoma; histology; ocular adnexa; prognostic factor.
Conflict of interest statement
The authors declare that there is no conflict of interest regarding the publication of this article.
Figures


Similar articles
-
Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.Cancer. 2003 Aug 15;98(4):865-71. doi: 10.1002/cncr.11539. Cancer. 2003. PMID: 12910532
-
Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.Ophthalmology. 1995 Dec;102(12):1994-2006. doi: 10.1016/s0161-6420(95)30764-6. Ophthalmology. 1995. PMID: 9098307
-
Outcome and prognostic factors in ocular adnexal lymphoma.Croat Med J. 2004 Jun;45(3):328-32. Croat Med J. 2004. PMID: 15185428
-
Ocular adnexal lymphomas: five case presentations and a review of the literature.Surv Ophthalmol. 2002 Sep-Oct;47(5):470-90. doi: 10.1016/s0039-6257(02)00337-5. Surv Ophthalmol. 2002. PMID: 12431695 Review.
-
Extranodal Marginal Zone B-cell Lymphoma of the Ocular Adnexa.Cancer Control. 2016 Apr;23(2):140-9. doi: 10.1177/107327481602300208. Cancer Control. 2016. PMID: 27218791 Review.
Cited by
-
Predictors of survival in gastric mucosa-associated lymphoid tissue lymphoma: An updated surveillance, epidemiology, and end results-based analysis of age and gender disparities.World J Clin Oncol. 2025 Jun 24;16(6):106408. doi: 10.5306/wjco.v16.i6.106408. World J Clin Oncol. 2025. PMID: 40585819 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources